110 related articles for article (PubMed ID: 17324334)
1. Clinical and immunologic profile of AIDS-related lymphoma in the era of highly active antiretroviral therapy.
Barclay LR; Buskin SE; Kahle EM; Aboulafia DM
Clin Lymphoma Myeloma; 2007 Jan; 7(4):272-9. PubMed ID: 17324334
[TBL] [Abstract][Full Text] [Related]
2. Profile of patients with Kaposi's sarcoma in the era of highly active antiretroviral therapy.
Gallafent JH; Buskin SE; De Turk PB; Aboulafia DM
J Clin Oncol; 2005 Feb; 23(6):1253-60. PubMed ID: 15718323
[TBL] [Abstract][Full Text] [Related]
3. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.
Besson C; Goubar A; Gabarre J; Rozenbaum W; Pialoux G; Châtelet FP; Katlama C; Charlotte F; Dupont B; Brousse N; Huerre M; Mikol J; Camparo P; Mokhtari K; Tulliez M; Salmon-Céron D; Boué F; Costagliola D; Raphaël M
Blood; 2001 Oct; 98(8):2339-44. PubMed ID: 11588028
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
[TBL] [Abstract][Full Text] [Related]
5. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
6. Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival.
Diamond C; Taylor TH; Aboumrad T; Anton-Culver H
Cancer; 2006 Jan; 106(1):128-35. PubMed ID: 16329140
[TBL] [Abstract][Full Text] [Related]
7. Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.
Hoffmann C; Wolf E; Fätkenheuer G; Buhk T; Stoehr A; Plettenberg A; Stellbrink HJ; Jaeger H; Siebert U; Horst HA
AIDS; 2003 Jul; 17(10):1521-9. PubMed ID: 12824790
[TBL] [Abstract][Full Text] [Related]
8. Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia.
Robotin MC; Law MG; Milliken S; Goldstein D; Garsia RJ; Dolan GM; Kaldor JM; Grulich AE
HIV Med; 2004 Sep; 5(5):377-84. PubMed ID: 15369514
[TBL] [Abstract][Full Text] [Related]
9. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
10. Liposomal doxorubicin, cyclophosphamide, and etoposide and antiretroviral therapy for patients with AIDS-related lymphoma: a pilot study.
Combs S; Neil N; Aboulafia DM
Oncologist; 2006 Jun; 11(6):666-73. PubMed ID: 16794245
[TBL] [Abstract][Full Text] [Related]
11. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
12. Incidence and management of AIDS-related lymphoma.
Levine AM; Seneviratne L; Tulpule A
Oncology (Williston Park); 2001 May; 15(5):629-39; discussion 639-40, 645-6. PubMed ID: 11396357
[TBL] [Abstract][Full Text] [Related]
13. Changes in acquired immunodeficiency syndrome-related lymphoma since the introduction of highly active antiretroviral therapy.
Matthews GV; Bower M; Mandalia S; Powles T; Nelson MR; Gazzard BG
Blood; 2000 Oct; 96(8):2730-4. PubMed ID: 11023505
[TBL] [Abstract][Full Text] [Related]
14. Report of AIDS-related lymphoma in South Korea.
Kim JS; Kim SJ; Kim JS; Kim ES; Shin HJ; Chung JS; Min YH; Lee MH; Choi YJ; Bang SM; Kim JA; Cho GJ; Chi HS; Jang SS; Park CJ; Suh C; Park CW; Kim CS;
Jpn J Clin Oncol; 2008 Feb; 38(2):134-9. PubMed ID: 18263652
[TBL] [Abstract][Full Text] [Related]
15. Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas.
Lascaux AS; Hemery F; Goujard C; Lesprit P; Delfraissy JF; Sobel A; Lepage E; Lévy Y
AIDS Res Hum Retroviruses; 2005 Mar; 21(3):214-20. PubMed ID: 15795527
[TBL] [Abstract][Full Text] [Related]
16. The changing face of HIV-associated lymphoma: what can we learn about optimal therapy inl the post highly active antiretroviral therapy era?
Clayton A; Mughal T
Hematol Oncol; 2004 Sep; 22(3):111-20. PubMed ID: 15991221
[TBL] [Abstract][Full Text] [Related]
17. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
Ives NJ; Gazzard BG; Easterbrook PJ
J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
[TBL] [Abstract][Full Text] [Related]
18. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART).
Wolf T; Brodt HR; Fichtlscherer S; Mantzsch K; Hoelzer D; Helm EB; Mitrou PS; Chow KU
Leuk Lymphoma; 2005 Feb; 46(2):207-15. PubMed ID: 15621803
[TBL] [Abstract][Full Text] [Related]
19. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
20. Evolving characteristics of AIDS-related lymphoma.
Levine AM; Seneviratne L; Espina BM; Wohl AR; Tulpule A; Nathwani BN; Gill PS
Blood; 2000 Dec; 96(13):4084-90. PubMed ID: 11110677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
